Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Karolinska Institutet
With
Scandinavian Critical Care Trials Group
Copenhagen Trial Unit, Center for Clinical Intervention Research
Centre for Research in Intensive Care (CRIC)
Aarhus University Hospital
Aalborg University Hospital
Copenhagen University Hospital, Rigshospitalet
Linkoeping University
Stockholm South General Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
confirmed SARS-CoV-2 AND
requiring at least 10l/min of O2 supplementation, non-invasive mechanical ventilation for hypoxia or invasive mechanical AND
\- randomised in the ICU
You may not be if
if previously randomised to the CS2 trial
if they had received corticosteroids for COVID-19 during ≥5 consecutive days or use corticosteroids in doses \>6 mg dexamethasone for an indication other than COVID-19.
active tuberculosis
hypersensitivity to dexa-/betamethasone
active fungal infection
fertile woman ≤60 years of age with a positive U-HCG/P-HCG test
informed consent not obtainable
For the inclusion in this post-hoc analyses there is additional criteria:
